Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 6, 1997, Pages 748-756

  Höper, Marius M ^b   Voelkel, Norbert F ^b   Bates, Thomas O ^b   Allard, Jenny D ^b   Horan, Marilee ^b   Shepherd, David ^b   Tuder, Rubin M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; PROSTAGLANDIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN VITRO STUDY; LUNG; MALE; METABOLISM; MONOCYTE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; LUNG; LYMPHOKINES; MALE; MONOCYTES; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031302955     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.6.2888     Document Type: Article

References (50)

1. Senger, D., C. A. Perruzzi, J. Feder, and H. F. Dvorak. 1986. A highly conserved vascular permeability factor secreted by a variety of human and rodent cell lines. Cancer Res. 46:5629-5632.
2. Ferrara, N., and W. J. Henzel. 1989. Pituitary follicular cells secret a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Comm. 161:851-858.
3. Gospodarowicz, L. E., J. A. Abraham, and J. Schilling. 1989. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. USA 86:7311-7315.
4. Leung, D. W., G. Cachianes, W. J. Kuang, D. W. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
5. Houck, K. A., N. Ferrara, J. Winer, G. Cachianes, B. Li, and D. W. Leung. 1991. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1806-1814.
6. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
7. Stavri, G. T., Y. Hong, I. C. Zacary, G. Breier, and P. A. Baskerville, S. Ylä-Herttuala, W. Risau, J. F. Martin, and J. D. Erusalimsky. 1995. Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS. Lett. 358:311-315.
8. Goldman, C. K., J. Kim, W. L. Wong, V. King, T. Brock, and G. Y. Gillespie. 1993. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma athophysiology. Mol. Biol. Cell 4:121-131.
9. Pertovaara, L., A. Kaipainen, T. Mustonen, A. Orpana, N. Ferrara, O. Saksela, and K. Alitalo. 1994. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem. 269:6271-6274.
10. Brogi, E., T. Wu, A. Namiki, and J. M. Isner. 1994. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxic upregulates VEGF expression only. Circulation 90:649-652.
11. Li, J., M. A. Perrella, J. C. Tsai, S. F. Yet, C. M. Hsieh, M. Yoshizumi, C. Patterson, W. O. Endege, F. Zhou, and M. E. Lee. 1995. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem. 270:308-312.
12. Claffey, K. P., W. O. Vilkinson, and B. M. Spiegelman. 1942. Vascular endothelial growth factor: regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 23:16317-16322.
13. Ferrara, N., K. A. Houck, L. B. Jakeman, J. Winer, and D.W. Leung. 1991. The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47:211-218.
14. Kim, K. J., B. Li, J. Winer, M. Armanini, N. Gillet, H. S. Phillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844.
15. Millauer, B., L. K. Shawver, K. H. Plate, W. Risau, and A. Ullrich. 1994. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579.
16. Sabia, P. J., E. R. Powers, M. Ragosta, I. J. Sarembock, L. R. Burwell, and S. Kaul. 1992. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N. Engl. J. Med. 327:1825-1831.
17. Banai, S., M. T. Jaklitsch, M. Shou, D. F. Lazarous, M. Scheinowitz, S. Biro, S. E. Epstein, and E. F. Linger. 1994. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulating 89:2183-2189.
18. Takeshita, S., L. P. Zheng, E. Brogi, M. Kearney, L. Q. Pu, S. Bunting, N. Ferrara, J. F. Symes, and J. M. Isner. 1994. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93: 662-670.
19. Tuder, R. M., B. E. Flook, and N. F. Voelkel. 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J. Clin. Invest. 95:1798-1907.
20. Tuder, R., and N. Voelkel. 1994. Vascular endothelial growth factor (VEGF) induction in primary pulmonary hypertension. J. Cell. Biochem. 18A:330.
21. Tuder, R. M., J. Allard, and N. F. Voelkel. 1996. Role of vascular endothelial growth factor in hypoxia and monocrotaline induced pulmonary hypertension. Circulation 94(Suppl.):1647.
22. Szczeklik, A., R. Nizankowski, J. Skawinski, G. Szcyeklik, P. Gluska, and R. J. Gryglewski. 1979. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet I:1111-1114.
23. Rubin, L. J., J. Mendoza, M. Hood, et al. 1990. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin. Ann. Intern. Med. 112:485-491.
24. Barst, R. J., L. J. Rubin, M. McGoon, E. J. Caldwell, W. A. Long, and P. S. Levy. 1994. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann. Intern. Med. 121:409-415.
25. Gomez-Sanchez, M. A., C. S. De La Calzada, C. G. Pajuelo, J. C. Tascon, M. Alonso, J. Andreu, M. Aranzana, and A. De La Fuente, 1991. Different hemodynamic responses between acute and chronic infusion of iloprost (prostacyclin-stable analogue) in severe pulmonary hypertension. Am. Rev. Respir. Dis. 144:1404-1405.
26. 2-receptors and molecular mechanisms in platelets and vasculature: slate of the art. Pharmacol. Res. Comm. 19:735-765.
27. Sinzinger, H. 1987. Monitoring the effectiveness of prostaglandin therapy in humans. In Prostacyclin and its Stable Analogue Iloprost. R. S. Gryglewski and G. Stock, editors. Springer, Berlin, Heidelberg, Germany. 293-294.
28. 1 in osteoblasts. J. Clin. Invest. 93:2490-2496.
29. Berse, B., L. F. Brown, L. Van de Water, H. F. Dvorak, and D. R. Senger. 1992. Vascular permeability factor (vascular endothelial cell growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3:211-220.
30. Tuder, R. M., A. Weinberg, N. Panajotopoulos, and J. Kalil. 1994. Cytomegalovirus infection amplifies class I major histocompatibilily complex expression in cultured human endothelial cells. J. Heart Lung Transplant 13:129-138.
31. Ono, S., J. Y. Wescott, and N. F. Voelkel. 1992. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats. J. Appl. Physiol. 73:1084-1092.
32. Chomczynski, P., and N. Sacchi. 1987. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
33. Terman, B., M. E. Carrian, E. Kovacs, A. Rasmussen, R. L. Eddy, and T. B. Shows. 1991. Identification of a new endothelial growth factor receptor tyrosine kinase. Oncogene 6:1677-1683.
34. Bradford, M. M. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
35. Skuballa, W., B. Radüchel, and H. Vorbrüggen. 1987. Chemistry of stable prostacyclin analogues: synthesis of iloprost. In Prostacyclin and Its Stable Analogue Iloprost. R. S. Gryglewski and G. Stock, editors. Springer, Berlin, Heidelberg, Germany. 17-24.
36. Coleman, R. A., W. L. Smith, and S. Narumiya. 1994. VIII. International union of pharmacology, classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacol. Rev. 46:206-229.
37. Pereira, M. E., D. L. Segaloff, M. Ascoli, and F. Eckstein. 1987. Inhibition of choriogonadotropin-activated steroidogenesis in cultured leydig tumor cells by the Rp diastereoisomer of adenosine 3′,5′-cyclic phosphorothioate. J. Biol. Chem. 262:6093-6100.
38. Hidaka, H., M. Inagaki, S. Kawamoto, and Y. Sasaki. 1984. Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5042.
39. Kase, H. 1987. K-252 compounds: novel and potent inhibitors of protein kinase C and cyclic nucleotide dependent protein kinases. Biochem. Biophys. Res. Comm. 142:436-140.
40. Basheeruddin, K., C. Rechtoris, and T. Mazzone. 1992. Transcriptional and post-transcriptional control of apolipoprotein E gene expression in differentiating human monocytes. J. Biol. Chem. 267(2):1219-1224.
41. Nakano, T., E. W. Raines, J. A. Abraham, F. G. Wenzel, S. Higashiyama, M. Klagsbrun, and R. Ross. 1993. Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. J. Biol. Chem. 264:22941-22947.
42. 2+ influx requires cAMP-dependent protein kinase in PC 12 cells. J. Biol. Chem. 266:17454-17458.
43. 2+. Proc. Natl. Acad. Sci. USA 87:2466-2470.
44. 2 production by isolated lungs and endothelial cells. J. Appl. Physiol. 57:388-345.
45. Greenberg, M., E. B. Ziff, and L. A. Greene. 1986. Stimulation of neuronal acetylcholine receptors induces rapid gene transcription. Science 234:80-83.
46. Rothman, A., B. Wolner, D. Button, and P. Taylor. 1994. Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary artery smooth muscle cells. J. Biol. Chem. 269:6399-6404.
47. Cooper, D. M. F., N. Mons, and J. Karpen. 1995. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374:421-424.
48. Park, J. E., G. A. Keller, and N. Ferrara. 1993. The VEGF isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix bound VEGF. Mol. Biol. Cell 4:1317-1326.
49. Monacci, W. T., M. J. Merrill, and F. H. Oldfiled. 1993. Expression of vascular permeability factor/vascular endothelial growth factor in rat tissues. Am. J. Physiol. 254:C950-C1002.
50. van der Zee, R., T. Murohara, T. Toyoaki, Z. Luo, F. Zollmann, J. Passeri, C. Lekutat, and J. M. Isner. 1997. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 95:1030-1037.